Drugmaker Eli Lilly's 1Q profit falls 15 percent (AP)
INDIANAPOLIS – Eli Lilly says its first-quarter profit fell 15 proportionality because of charges for restructuring and a diabetes take development commendation with Boehringer Ingelheim.
The Indianapolis consort says it earned $1.06 billion, or 95 cents per share, in the three months that ended March 31. That's downbound from $1.25 billion, or $1.13 per share, in the same lodge terminal year. Revenue chromatic 6 proportionality to $5.84 billion.
Excluding the charges, Lilly's profit was $1.24 per share.
Analysts surveyed by FactSet expect, on average, earnings of $1.17 per deal on $5.71 1000000000 in revenue.
Sales for Lilly's best-selling drug, the antiemetic Zyprexa, climbed 6 proportionality to $1.28 billion. Revenue from its second-best seller, the antidepressant Cymbalta, chromatic 13 proportionality to $909 million.
Source
0 comments:
Post a Comment